Stock ANN ANSELL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Ansell Limited

Equities

ANN

AU000000ANN9

Market Closed - Australian S.E.
Other stock markets
 02:10:45 2024-04-26 am EDT 		5-day change 1st Jan Change
25.3 AUD -0.55% Intraday chart for Ansell Limited +1.98% +0.48%
Apr. 15 Ansell Launches AU$65 Million Share Purchase Plan MT
Apr. 10 JPMorgan Upgrades Ansell to Overweight from Neutral, Price Target is AU$29.20 MT

Summary

  • According to Refinitiv, the company's ESG score for its industry is good.

Strengths

  • Sales forecast by analysts have been recently revised upwards.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.

Weaknesses

  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • The company benefits from high valuations in earnings multiples.
  • For the past year, analysts have significantly revised downwards their profit estimates.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ANSELL LIMITED Stock Ansell Limited
+0.48% 2.34B
B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.15% 185B
C+
MEDTRONIC PLC Stock Medtronic plc
-3.30% 105B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.62% 66.59B
A
DEXCOM, INC. Stock DexCom, Inc.
+1.66% 54.66B
B-
CENCORA, INC. Stock Cencora, Inc.
+17.27% 47.78B
B-
HOYA CORPORATION Stock Hoya Corporation
+4.06% 41.26B
B+
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.04% 26.95B
A-
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.19% 26.37B
B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.8B
A-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ANN Stock
  4. Ratings Ansell Limited